268 - Outpatient CAR T Cell Therapy Is Safe and Feasible in Patients with Lymphoma Treated in Non-University Medical Centers: A Multicenter, Retrospective Analysis

Publication Title

Transplantation and Cellular Therapy

Authors

• Krish Patel, Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA, USAFollow
• Megumi Bailey, Swedish Medical Center, Seattle, Washington, United States.Follow
• Neil Bailey, Swedish Cancer Center, Seattle, WAFollow
• Suzanne Fanning, Swedish Cancer Center, Seattle, WA
• Kayla Gulley, Swedish Cancer Center, Seattle, WA
• Jens Frisvold, Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Swedish Medical Center, Seattle, WA, USA.Follow
• Sonia Glennie, Swedish Cancer Center, Seattle, WA
• Vanessa Dunleavy, Swedish Medical Center, Seattle, Washington, United States.Follow
• Sandra Benitez-Kruidenier, Swedish Cancer Center, Seattle, WA
• Julia Parker, Swedish Cancer Center, Seattle, WA
• Shannon Williams, Swedish Cancer Center, Seattle, WA
• Suzan Sullivan, Swedish Cancer Center, Seattle, WA
• Carol Dean, Swedish Cancer Center, Seattle, WA
• Heidi Hohmann, Swedish Cancer Center, Seattle, WA
• Chiachun Lu, Swedish Cancer Center, Seattle, WA
• Catherine Tierney, Swedish Cancer Center, Seattle, WA
• Grace Mun, Swedish Cancer Center, Seattle, WA
• Daniel N Egan, Department of Medicine, Swedish Medical Center, Seattle, WA, United States.Follow
• James Essell, Swedish Cancer Center, Seattle, WA

Document Type

Abstract

Publication Date

2-2023

Keywords

washington; swedish; swedish cancer

Area of Special Interest

Cancer

Specialty/Research Institute

Oncology

Specialty/Research Institute

Hematology